Search results
Roche (RHHBY) Q1 Revenues Decline on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 1 year agoSwiss pharma giant Roche Holding AG’s RHHBY first-quarter revenues declined 7% to CHF 15.3 billion...
Roche Follows Merck, Sanofi Into A Red-Hot Immunology Space With A $7.1 Billion Buyout
Investor's Business Daily· 6 months agoSwiss drugmaker Roche said Monday it has agreed to buy an experimental immunology drug from Roivant...
Roche buys U.S. rights to Roivant bowel disease drug in $7.1 billion deal
Reuters via Yahoo Finance· 6 months agoZURICH/FRANKFURT (Reuters) -Switzerland's Roche has agreed to pay an initial $7.1 billion to Roivant...
Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale
Zacks via Yahoo Finance· 7 months agoRoche (RHHBY) reports a sales decline in the first nine months of 2023 as COVID-19-test sales...
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
Zacks via Yahoo Finance· 3 months agoRoche (RHHBY) misses earnings and sales estimates in 2023 due to a significant decline in...
Drug Heavyweights GSK, Roche Topple As Covid Weighs On Sales Growth
Investor's Business Daily· 1 year agoEuropean pharmaceutical giants GSK and Roche leaned on vaccine and pharma sales, respectively, to...
The Zacks Analyst Blog Highlights J&J, Roche, Eli Lilly and AbbVie
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – October 24, 2022 – Zacks.com announces the list of stocks...
Is Roche a Buy Now?
Motley Fool· 1 year agoSwiss healthcare company Roche Holding (OTC: RHHBY) doesn't trade on the NYSE or NASDAQ, so the company is sometimes overlooked considering its size,...
Roche (RHHBY) Gets EC Approval for Polivy Combination in DLBCL
Zacks via Yahoo Finance· 2 years agoRoche RHHBY recently announced that the European Commission (“EC”) has granted approval to lymphoma...
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Motley Fool· 1 year agoRoche Holding (OTC: RHHBY) and Gilead Sciences (NASDAQ: GILD) both saw increased sales during the...
